眼科 ›› 2013, Vol. 22 ›› Issue (5): 351-353.

• 论著 • 上一篇    下一篇

帕瑞昔布钠对眼内容剜除联合义眼座植入手术后镇痛效果的影响

袁一飞 张锐, 钱江 付海滨, 万凌光   

  1. 200031 上海,复旦大学附属眼耳鼻喉科医院眼科(袁一飞、张锐、钱江); 麻醉科(付海滨),护理部(万凌光)
  • 收稿日期:2012-09-15 出版日期:2013-09-25 发布日期:2013-09-29
  • 通讯作者: 钱江,Email:qianjiang58@163.com
  • 基金资助:

    国家自然科学基金青年项目(81100656/H1203),上海市科委医学引导类项目(114119a7200)

Postoperative analgesic effects of parecoxib sodium on the surgery of evisceration with implantation

 YUAN  Yi-Fei- Zhang-Rui, QIAN  Jiang- Fu-Hai-Bin, WAN  Ling-Guang   

  1. 1. Department of Ophthalmology, 2. Department of Anesthesiology, 3.Department of Nursing, Eye and ENT Hospital, Fudan University, Shanghai 200031, China
  • Received:2012-09-15 Online:2013-09-25 Published:2013-09-29
  • Contact: QIAN Jiang, Email:qianjiang58@163.com

摘要: 目的 观察帕瑞昔布钠对眼内容剜除联合义眼座植入手术患者术后镇痛效果的影响。设计 随机对照临床试验。研究对象 复旦大学附属眼耳鼻喉科医院眼科连续收治的在全麻下行眼内容剜除联合义眼座植入手术的患者60例。方法 采用随机数字表法将以上患者分为两组,A组在全麻诱导前和手术结束前分别静脉注射帕瑞昔布钠40 mg,术后第1天起每天2次给予肌肉注射帕瑞昔布钠40 mg,共2天;B组在上述时间点静脉注射或肌肉注射2 ml生理盐水。采用视觉模拟评分法(VAS)记录苏醒后即刻(T1)、术后4 h(T2)、24 h(T3)、48 h(T4)的镇痛效果,观察药物的副作用。主要指标 VAS评分,药物副作用。结果 T1~T3时A组VAS评分分别为1.83±0.70、1.17±0.65、0.93±0.58; B组VAS评分分别为2.87±1.04、2.30±0.92、1.40±0.62。A组评分明显低于B组,差异有统计学意义(P均=0.000)。T4时两组评分分别为0.57±0.50、0.67±0.57,两组比较差异无统计学意义(P=0.051)。未观察到帕瑞昔布钠明显的副作用。结论 帕瑞昔布钠对于眼内容剜除联合义眼座植入手术的患者术后早期(24小时内)具有良好的镇痛作用。(眼科,2013, 22: 351-353)

关键词:  , 帕瑞昔布钠;眼内容剜除术;义眼座植入手术;术后镇痛

Abstract: Objective  To investigate the postoperative analgesic effects of parecoxib sodium on the surgery of evisceration with implantation. Design Randomized controlled clinical trial. Participants Continuous 60 patients undergoing evisceration with implantation surgery under general anesthesia in department of ophthalmology, Eye and ENT Hospital, Fudan University. Methods Sixty patients undergoing evisceration with implantation surgery under general anesthesia were randomly divided into 2 groups of thirty: Group A received parecoxib sodium 40 mg by intravenous injection before anesthesia induction and before the end of surgery. Parecoxib sodium 40 mg was also administrated by muscle injection twice a day in the next two days postoperatively. Group B received 2 ml saline by intravenous injection or by muscle injection at the same time. Visual analog score (VAS) was recorded to evaluate postoperative pain at the time of analepsia  (T1), 4 h(T2), 24 h(T3) and 48 h(T4) after the surgery. Side effects of parecoxib sodium were also recorded. Main Outcome Measures Visual analog score, side effects. Results The VAS scores at T1-T3 in Group A were 1.83±0.70, 1.17±0.65, 0.93±0.58. The VAS scores at T1-T3 in Group B were 2.87±1.04, 2.30±0.92, 1.40±0.62. The VAS scores in Group A were significantly lower as compared with those in Group B(all P<0.05). There was no significant difference of VAS score between Group A and Group B at T4(0.57±0.50 in Group A and 0.67±1.57 in Group B, P>0.05). No serious side effects were observed during the use of parecoxib sodium. Conclusion Administration of parecoxib sodium can provide good analgesia effects during early period after the surgery of evisceration with implantation. (Ophthalmol CHN, 2013, 22: 351-353)

Key words: parecoxib sodium, evisceration, implantation surgery, postoperative analgesia